Ingredion (INGR) Q3 2026 earnings review
Ingredion cuts its profit outlook as factory costs sink earnings
Ingredion, which turns corn and other crops into sweeteners and food starches, missed its own profit plan across all three main divisions. Sales from continuing businesses edged up 2%, but operating profit excluding one-offs fell 19% to $206 million — nearly triple the mid-single-digit drop management planned for. Chief executive Jim Zallie cut the full-year profit outlook for a third straight quarter, leaving fourth-quarter profit per share on track to fall 20% by our math.
| Sales from businesses owned a year ago | +2% reported net sales -1% ($1,792M) |
|---|---|
| Operating income, excluding one-offs | $206M -19% from a year ago (planned: down ~5%) |
| Profit per share, excluding one-offs | $2.28 -17% from a year ago |
| Full-year EPS outlook, excluding one-offs | Cut $1.13 new range $9.25–9.70 (-15% at middle) |
⚖️ Verdict: 🔴 Bearish
The story got worse because both halves of the bull case broke in the same quarter. The expected second-half profit rebound at the troubled Argo plant in Chicago failed to appear, as North American profit fell below second-quarter levels. At the same time, rising tapioca and factory costs turned volume gains in the flagship specialty division into a 10% profit decline. One bright spot: Ingredion resumed share buybacks with $71 million spent and hired permanent finance chief Diego Reynoso.
The question now is whether North American factory costs and specialty ingredient margins can recover through pricing and cost cuts in 2027, or if weak food and beverage demand prevents Ingredion from passing inflation on to customers. If cost cuts and tapioca pricing work, profit rebounds early next year; if customer demand stays soft, margins stay compressed as the company takes on debt to buy Tate & Lyle. Fourth-quarter segment margins and 2027 contract pricing commentary will tell.
🐂 Bull Case
Buybacks Resumed and Permanent Finance Chief Appointed
Two standing concerns around capital execution and leadership eased this quarter. Ingredion had bought back only $14 million of shares in the first half of the year, including zero in the second quarter, while repeating a $100 million full-year target. In the third quarter, the ingredient maker spent $71 million on share repurchases, bringing the nine-month total to $85 million and putting the annual target within reach.
The US group also resolved its leadership gap in the finance department. After operating with an interim finance chief for two straight quarters while negotiating and hedging the pending Tate & Lyle buyout, the company named Diego Reynoso as executive vice president and chief financial officer. In addition, the board raised the quarterly dividend to $0.83 per share, marking its twelfth straight annual increase.
What to watch: fourth-quarter share repurchases in the full-year cash flow statement. Completing the final $15 million will confirm that management met its capital return target despite lower operating cash flow.
Portfolio Reshaping Lifts Underlying Sales
Headline net sales fell 1% to $1,792 million because Ingredion sold its majority stake in its Pakistan business at the end of June. That sale removed $65 million of quarterly revenue. Excluding the divested Pakistan unit, sales from businesses owned a year ago rose 2%, helped by favorable currency rates and volume gains in Latin America and specialty ingredients.
Inside the smaller All Other segment — which houses sugar-reduction ingredients and pea protein — operating losses widened by $7 million to $11 million solely because Pakistan contributed $9 million of profit a year ago. The remaining businesses in that group added $2 million of profit improvement from a year ago, driven by continued progress in Protein Fortification. Note disclosures did not update revenue for higher-value industrial barrier coatings this quarter.
What to watch: standalone revenue and profit disclosures for Protein Fortification in the annual filing. Continued profit gains there must offset the permanent loss of Pakistan earnings in the All Other segment.
🐻 Bear Case
Argo Recovery Stalls and Forces Outlook Cut
Food & Industrial Ingredients—U.S./CAN is Ingredion's North American sweeteners and starches division, where the large Argo plant in Chicago has suffered reliability failures for over a year. Last quarter, management said Argo had returned to normal run rates and predicted margins would recover by year-end. Instead, chief executive Jim Zallie said third-quarter results missed internal plans: "While we expect these actions to improve earnings, the recovery is taking longer than we expected."
- U.S./Canada segment operating income: $52 million, down 36% from a year ago and down 10% from last quarter's $58 million
- Unallocated Argo thermal event charges: $8 million in the third quarter and $25 million year-to-date, excluded from segment profit
- Full-year U.S./Canada profit outlook: cut to a 35–40% decline, down from the 20–25% drop planned three months ago
- Implied fourth-quarter segment profit: about $53 million by our math, down from $56 million a year ago
Even though Argo's production stayed stable and inventories were rebuilt, high factory expenses and weak customer demand prevented a profit rebound. Because North America failed to step up, Zallie cut the company's full-year profit outlook for the third quarter in a row. By our math, the new plan wipes out the fourth-quarter profit rebound management previously counted on.
What to watch: U.S./Canada segment operating income in the fourth quarter. A reading stuck near $53 million will mean cost reductions at Argo are not yet reaching the bottom line going into 2027.
Input Costs Turn Specialty Volume Into Profit Drop
Texture & Healthful Solutions is Ingredion's specialty division, making starches and clean-label ingredients that help food makers replace artificial additives. Three months ago, management raised this division's full-year profit forecast to mid-to-high single-digit growth after nine straight quarters of volume gains. In the third quarter, volume grew for a tenth consecutive quarter, rising about 2% from a year ago by our math, but that slowed from 7% growth in the second quarter.
Higher volume did not translate into higher earnings. Segment operating income fell 10% from a year ago to $95 million because "higher tapioca costs and manufacturing input cost inflation negatively impacted profit growth in the segment", Zallie said. Price and product mix also subtracted $4 million from sales. Management reversed last quarter's raise and cut the division's full-year profit outlook back to flat to up low single digits.
What to watch: price and product mix in Texture & Healthful Solutions next quarter. Management previously said tapioca price increases take one to one-and-a-half quarters to pass through, so fourth-quarter pricing will test whether the specialty unit can recover its margin.
North American Volume Drop and Peso Drag Persist
Across its core sweetener and industrial starch businesses, Ingredion continues to face macro and demand pressures that pricing alone has not solved. In U.S./Canada, softer food and beverage customer demand reduced third-quarter sales by $15 million, or about 3% by our math, extending a two-year industry volume slump. Favorable price and product mix added $13 million, leaving North American revenue down 1% at $504 million.
In Latin America (Food & Industrial Ingredients—LATAM), higher volumes sold to brewing and beverage customers in Mexico and Brazil lifted net sales by 7% to $624 million. Even so, segment operating income fell 6% to $109 million — and dropped 10% excluding currency translation — due to an August earthquake in Colombia and a stronger Mexican peso, which raises local operating costs against dollar-priced sales. Management cut its full-year Latin America profit forecast to a mid-to-high single-digit drop.
What to watch: 2027 annual contract pricing commentary on the fourth-quarter call. It will show whether North American sweetener prices can cover unrecovered factory inflation while industry volumes remain weak.
Deal Costs Mount as Operating Cash Shrinks
Ingredion is preparing to buy UK ingredient maker Tate & Lyle in an all-cash deal to
create what Zallie called "the foundation for an even stronger company" in 2027 and beyond. Before the deal even closes, acquisition and integration charges have reached $59 million year-to-date, including $42 million of currency hedging losses ($5 million in the third quarter). Meanwhile, nine-month cash from operations fell 28% from a year ago to $389 million, prompting management to cut its full-year operating cash flow outlook by $50 million to a range of $650 million to $750 million.
What to watch: full-year cash from operations against the $450–490 million capital spending budget and $210 million dividend outlay. The narrowing cash buffer leaves little room to pay down debt before taking on acquisition borrowings, and regulatory approvals in 11 jurisdictions remain pending.
💲 Other KPIs
Gross margin fell 2.8 percentage points from a year ago and 0.7 points from last quarter. Cost of sales — the direct cost of raw materials like corn and tapioca plus factory expenses — climbed to 77.7% of net sales from 74.9% a year ago. Overhead and administrative expenses also rose 0.8 points to 12.0% of sales.
Money owed by customers has grown 13.6% since December 2025, even though nine-month net sales fell 1%. While receivables dipped $40 million from June, the year-to-date working capital build has drained $219 million of operating cash over the first nine months of 2026.
Debt due within one year rose from $48 million at year-end 2025 as $500 million of long-term debt moved into current liabilities. Total debt sits at $1.78 billion against $993 million of cash and short-term investments, leaving net debt roughly steady at $782 million.
🔮 Guidance
Cut. The middle of the range fell by $1.13 per share, pointing to a 15% full-year profit drop from $11.13 in 2025. By our math, that leaves $1.80 to $2.25 for the fourth quarter, down 20% from a year ago at the middle of the range. This is the third straight quarterly cut to the 2026 outlook: -$0.60 in Q1, -$0.20 in Q2, and -$1.13 in Q3.
Cut. The middle of the range dropped by $1.19 per share, leaving full-year reported profit per share down 26% from 2025. By our math, the outlook implies $1.80 to $2.25 in the fourth quarter before any new acquisition, restructuring, or impairment charges.
Cut. Total sales are now expected to be flat rather than flat to up low single digits, as lower price mix and the Pakistan sale offset volume gains and currency tailwinds. Excluding Pakistan, the underlying sales plan holds at flat to up low single digits.
Cut. Management lowered the outlook by about 10 percentage points after the U.S./Canada recovery stalled. By our math, a 15% full-year decline implies about $198 million of operating profit in the fourth quarter, down 13% from $228 million a year ago.
Unchanged. The full-year wording stayed at a low double-digit drop because a $17 million third-quarter restructuring gain from selling land in Lane Cove, Australia cushioned the operational miss.
Cut. Management reversed last quarter's raise due to tapioca and factory cost inflation. By our math, a 1.5% full-year increase implies roughly $99 million of fourth-quarter segment profit, up 10% from $90 million a year ago.
Cut. The outlook worsened on continued strength in the Mexican peso and the Colombia earthquake disruption. Nine-month segment profit is already down 8% from a year ago.
Cut. This is the third downgrade to the North American outlook this year, after starting 2026 expecting flat profit. By our math, the middle of the new range leaves about $53 million of segment profit for the fourth quarter.
Unchanged. Nine-month operating loss sits at $2 million, implying a fourth-quarter loss of roughly $13 million without the divested Pakistan unit.
Unchanged. Nine-month corporate expenses fell 14% from a year ago to $120 million, reflecting ongoing spending controls.
Raised at the bottom of the range. Both tax rate ranges narrowed upward by 0.5 percentage points at the low end.
Cut. Lowered by $50 million at both ends — the third cut this year from the initial $820–940 million target. By our math, reaching the $700 million midpoint requires $311 million of operating cash in the fourth quarter.
Unchanged. Nine-month capital spending reached $313 million, leaving $137 million to $177 million for the fourth quarter.
❓ Key Questions
Why did Argo manufacturing costs stay high after production stabilized?
Management said Argo ran reliably for a second straight quarter and rebuilt its inventory, yet U.S./Canada profit fell from $58 million in Q2 to $52 million in Q3. Investors need to know how much of the cost drag is permanent inflation versus temporary fix-up work.
When will specialty pricing catch up with tapioca cost inflation?
Last quarter, executives said tapioca price pass-through takes one to one-and-a-half quarters. Because Texture & Healthful Solutions profit fell 10% in Q3 and its full-year plan was cut, management should clarify whether customer pushback is delaying those price increases.
How much of specialty volume growth came from internal plant transfers?
In the second quarter, part of Texture & Healthful Solutions volume growth came from native-starch production moved over from the Argo plant. Management did not disclose the split in Q3, when segment volume growth slowed to about 2%.
What are the remaining regulatory milestones for the Tate & Lyle buyout?
The deal requires antitrust clearance across 11 jurisdictions, including the United States, UK, EU, and China. The Q3 release gave no update on specific country clearances while pre-close acquisition and hedging charges reached $59 million year-to-date.